BACKGROUND: For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV prevention technologies (NPTs) to have an impact on the epidemic, they must be widely used. This study uses a discrete choice experiment (DCE) to: understand the relative strength of women's preferences for product characteristics, understand the implications for substitution away from male condoms, and inform realistic modelling of their potential impact and cost-effectiveness. METHODS: A DCE was conducted among 1017 women in urban South Africa. Women were presented with choices between potential women's NPTs (microbicides, diaphragm, female condom) and 'what I did last time' ...
Background: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compar...
New biomedical prevention technologies (NPTs) for HIV, including oral Pre-Exposure Prophylaxis, and ...
Background: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compar...
Background: For the first time in the history of HIV, new bio-medical interventions have been shown ...
<div><p>Background</p><p>For the first time in the history of HIV, new bio-medical interventions hav...
BACKGROUND: The development of antiretroviral (ARV)-based prevention products has the potential to s...
INTRODUCTION: A number of antiretroviral HIV prevention products are efficacious in preventing HIV i...
The development of antiretroviral (ARV)-based prevention products has the potential to substantially...
Although there have been recent advances in HIV treatment, women still do not have a means to prote...
Designing strategies to introduce new HIV prevention technologies requires balancing equitable acces...
Evidence suggests that economic factors play an important role in commercial sex work, in particular...
BACKGROUND: There is little data on contraceptive effectiveness or use patterns from sub-Saharan Afr...
This thesis aims to deepen our understanding of the impact and cost-effectiveness of new HIV prevent...
Thesis (Ph.D.)--University of Washington, 2019Introduction Options for both contraception and HIV-1 ...
Abstract New forms of HIV pre-exposure prophylaxis (PrEP) include long-acting injectables and topica...
Background: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compar...
New biomedical prevention technologies (NPTs) for HIV, including oral Pre-Exposure Prophylaxis, and ...
Background: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compar...
Background: For the first time in the history of HIV, new bio-medical interventions have been shown ...
<div><p>Background</p><p>For the first time in the history of HIV, new bio-medical interventions hav...
BACKGROUND: The development of antiretroviral (ARV)-based prevention products has the potential to s...
INTRODUCTION: A number of antiretroviral HIV prevention products are efficacious in preventing HIV i...
The development of antiretroviral (ARV)-based prevention products has the potential to substantially...
Although there have been recent advances in HIV treatment, women still do not have a means to prote...
Designing strategies to introduce new HIV prevention technologies requires balancing equitable acces...
Evidence suggests that economic factors play an important role in commercial sex work, in particular...
BACKGROUND: There is little data on contraceptive effectiveness or use patterns from sub-Saharan Afr...
This thesis aims to deepen our understanding of the impact and cost-effectiveness of new HIV prevent...
Thesis (Ph.D.)--University of Washington, 2019Introduction Options for both contraception and HIV-1 ...
Abstract New forms of HIV pre-exposure prophylaxis (PrEP) include long-acting injectables and topica...
Background: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compar...
New biomedical prevention technologies (NPTs) for HIV, including oral Pre-Exposure Prophylaxis, and ...
Background: Young women in sub-Saharan Africa bear a disproportionate burden of HIV infection compar...